NYSE:IVC - Invacare Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $4.80 -0.21 (-4.19 %) (As of 12/14/2018 04:00 PM ET)Previous Close$5.01Today's Range$4.77 - $5.0152-Week Range$4.66 - $20.00Volume497,204 shsAverage Volume473,940 shsMarket Capitalization$173.30 millionP/E Ratio-2.49Dividend Yield0.96%Beta1.93 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through four segments: North America/Home Medical Equipment, Institutional Products Group, Europe, and the Asia/Pacific. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products. The company also provides lifestyle products, including pressure relieving overlays and mattress replacement systems under the Invacare Softform and microAIR brands; safe resident handling products; residential care and home beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Perfecto2, Perfecto2 V, and Platinum brands; Invacare HomeFill oxygen systems; and Invacare SOLO2 and XPO2 transportable oxygen concentrators. Further, it sells and distributes healthcare furnishings consisting of long-term care beds, case goods, safe patient handling equipment, and other equipment and accessories for long-term care customers. It sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, distributors, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio. Receive IVC News and Ratings via Email Sign-up to receive the latest news and ratings for IVC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Surgical appliances & supplies Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNYSE:IVC Previous Symbol CUSIP46120310 Webwww.invacare.com Phone440-329-6000 Debt Debt-to-Equity Ratio0.68 Current Ratio2.05 Quick Ratio1.34 Price-To-Earnings Trailing P/E Ratio-2.49 Forward P/E Ratio-3.10 P/E GrowthN/A Sales & Book Value Annual Sales$966.50 million Price / Sales0.16 Cash FlowN/A Price / Cash FlowN/A Book Value$10.80 per share Price / Book0.44 Profitability EPS (Most Recent Fiscal Year)($1.93) Net Income$-76,540,000.00 Net Margins-6.17% Return on Equity-12.98% Return on Assets-5.04% Miscellaneous Employees4,200 Outstanding Shares33,200,000Market Cap$173.30 million OptionableOptionable Invacare (NYSE:IVC) Frequently Asked Questions What is Invacare's stock symbol? Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC." How often does Invacare pay dividends? What is the dividend yield for Invacare? Invacare declared a quarterly dividend on Thursday, November 29th. Shareholders of record on Friday, January 4th will be given a dividend of $0.0125 per share on Thursday, January 17th. This represents a $0.05 dividend on an annualized basis and a yield of 1.04%. The ex-dividend date of this dividend is Thursday, January 3rd. View Invacare's Dividend History. How were Invacare's earnings last quarter? Invacare Co. (NYSE:IVC) issued its quarterly earnings results on Monday, November, 5th. The health services provider reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.30) by $0.10. The health services provider earned $244.60 million during the quarter, compared to analyst estimates of $250.59 million. Invacare had a negative net margin of 6.17% and a negative return on equity of 12.98%. The company's revenue for the quarter was down 2.5% on a year-over-year basis. During the same quarter last year, the firm earned ($0.41) EPS. View Invacare's Earnings History. When is Invacare's next earnings date? Invacare is scheduled to release their next quarterly earnings announcement on Wednesday, February 6th 2019. View Earnings Estimates for Invacare. What price target have analysts set for IVC? 2 brokers have issued 1-year price targets for Invacare's stock. Their forecasts range from $23.00 to $23.00. On average, they anticipate Invacare's stock price to reach $23.00 in the next twelve months. This suggests a possible upside of 379.2% from the stock's current price. View Analyst Price Targets for Invacare. What is the consensus analysts' recommendation for Invacare? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Invacare in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Invacare. Has Invacare been receiving favorable news coverage? News coverage about IVC stock has trended somewhat negative on Friday, according to InfoTrie Sentiment. The research firm rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Invacare earned a coverage optimism score of -1.1 on InfoTrie's scale. They also assigned media headlines about the health services provider a news buzz of 8.0 out of 10, meaning that recent media coverage is very likely to have an effect on the company's share price in the immediate future. Who are some of Invacare's key competitors? Some companies that are related to Invacare include Establishment Labs (ESTA), Sientra (SIEN), RTI Surgical (RTIX), Lakeland Industries (LAKE), Histogenics (HSGX), ConforMIS (CFMS), Bionik Laboratories (BNKL), COLLPLANT HOLDI/S (CLGN), NanoVibronix (NAOV), Precision Therapeutics (AIPT), Allied Healthcare Products (AHPI), Rewalk Robotics (RWLK), Wound Management Technologies (WNDM), Avitar (AVTI) and Halyard Health (HYH). Who are Invacare's key executives? Invacare's management team includes the folowing people: Mr. Matthew E. Monaghan, Chairman, Pres & CEO (Age 50)Ms. Kathleen P. Leneghan, Sr. VP & CFO (Age 55)Mr. Anthony C. LaPlaca, Sr. VP, Gen. Counsel & Sec. (Age 60)Mr. Ralf Ledda, Sr. VP & GM of EMEA (Age 50)Lois Lee, Director of Treasury and Investor Relations Who are Invacare's major shareholders? Invacare's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (15.40%), Vanguard Group Inc. (9.91%), Vanguard Group Inc (9.91%), Dimensional Fund Advisors LP (8.42%), Elk Creek Partners LLC (5.90%) and Royce & Associates LP (5.24%). Company insiders that own Invacare stock include Anthony Laplaca, Baiju R Shah, C Martin Harris, Clifford D Nastas, Dale C Laporte, Dean J Childers, Kathleen P Leneghan and Matthew E Monaghan. View Institutional Ownership Trends for Invacare. Which institutional investors are selling Invacare stock? IVC stock was sold by a variety of institutional investors in the last quarter, including Northpointe Capital LLC, Marshall Wace North America L.P., Wells Fargo & Company MN, United Services Automobile Association and Factorial Partners LLC. Company insiders that have sold Invacare company stock in the last year include Anthony Laplaca, Baiju R Shah, C Martin Harris and Dean J Childers. View Insider Buying and Selling for Invacare. Which institutional investors are buying Invacare stock? IVC stock was bought by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, Elk Creek Partners LLC, Dalton Greiner Hartman Maher & Co., BlackRock Inc., Royce & Associates LP, Vanguard Group Inc, Vanguard Group Inc. and Marshall Wace LLP. Company insiders that have bought Invacare stock in the last two years include Clifford D Nastas, Kathleen P Leneghan and Matthew E Monaghan. View Insider Buying and Selling for Invacare. How do I buy shares of Invacare? Shares of IVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Invacare's stock price today? One share of IVC stock can currently be purchased for approximately $4.80. How big of a company is Invacare? Invacare has a market capitalization of $173.30 million and generates $966.50 million in revenue each year. The health services provider earns $-76,540,000.00 in net income (profit) each year or ($1.93) on an earnings per share basis. Invacare employs 4,200 workers across the globe. What is Invacare's official website? The official website for Invacare is http://www.invacare.com. How can I contact Invacare? Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44035. The health services provider can be reached via phone at 440-329-6000 or via email at [email protected] MarketBeat Community Rating for Invacare (NYSE IVC)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 174 (Vote Outperform)Underperform Votes: 211 (Vote Underperform)Total Votes: 385MarketBeat's community ratings are surveys of what our community members think about Invacare and other stocks. Vote "Outperform" if you believe IVC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IVC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/14/2018 by MarketBeat.com StaffFeatured Article: What is the float in trading stocks?